Skip to main content

Emergence of Covid-19 and High Prevalence of Congenital Heart Disease in Infants to Augment Growth of Fetal and Neonatal Monitoring Market

 


Fetal and neonatal monitoring is a technique of monitoring your newborn's heart and lungs before, during, and after he/she was born. Normally the mother passes all of her body functions to the baby via vaginal deliveries or breastfeeding. A monitor is inserted into the birth canal to detect any irregularities in breathing, heartbeat, or pumping. These monitors are also used in early detection of any problems associated with your unborn baby such as congenital heart disease, breathing difficulties, or infections.

Market Dynamics

High prevalence of congenital heart disease in infants is expected to propel growth of the fetal and neonatal monitoring market. For instance, according to the study, Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study (published in May 2018), the prevalence of congenital heart disease (CHD) was 10.13/1000 live births. Moreover, emergence of Covid-19 is also expected to aid in growth of the market. For instance, in July 2020, Koninklijke Philips N.V. launched Avalon CL Fetal and Maternal Pod and Patch capable of providing “continuous non-invasive monitoring” of important vital signs such as maternal heart rate, fetal heart rate, and uterine activity.

High rate of maternal mortality in emerging economies is expected to offer lucrative growth opportunities for players in the fetal and neonatal monitoring market. For instance, according to Maternal Mortality: 1990 to 2015 Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division, Sub-Saharan Africa recorded the highest ratio or maternal mortality, at 555 per 100, 000 live births, from 1990 to 2015. Moreover, the United Nations is focused on achieving the Sustainable Development Goals 2015 - 2030 global maternal mortality ratio target of less than 70 per 100 000 live births.

Among regions, North America is expected to witness significant growth in the fetal and neonatal monitoring market, owing to increasing preterm birth rate in the U.S. For instance, according to March of Dimes 2019 report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63% in 2015.

Competitive Analysis

Major players operating in the fetal and neonatal monitoring market include, Becton, Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG & Co. KGAA, Cooper Surgical, Getinge AB, MindChild Medical, Inc., Natus Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh, Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation, Spacelabs Healthcare Inc., Smiths Medical, and Masimo.

Major players operating in the fetal and neonatal monitoring market are focused on adopting partnership strategies to enhance their market share. For instance, in April 2019, Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., and MindChild Medical, Inc. signed an exclusive distribution and supply agreement for the MERIDIAN M110 Fetal Monitoring System.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more